13 Feb, 2019
Tollbooth Index rose 88.11 to 15,581.74 and for the year-to-date soared 10.9%.
Apple Inc, edged up 65 cents to $171.54 after the research company International Data Corp reported that shipments of smart-phone in the fourth-quarter of fiscal 2018 declined by 20%
Apple no longer reports sales breakdown and the China sales weakness forced the smartphone maker lower its rare revenue forecast.
However, sales of China-based Huawei Technologies Co sales surged by 23% and Oppo and Vivo took second and third place in China.
Barrick Gold Corp, declined 5.1% or 68 cents to $12.69 after Canada-based gold miner reported revenues in the fourth-quarter ending in December dropped 13.6% from a year ago to $1.9 billion.
Net loss in the quarter widened to $1.2 billion or $1.02 per diluted share from $314 million or 27 cents in the same quarter last year.
The gold producer said production in the quarter was 1.26 million ounces, cost of sales was $980 per ounce and all-in sustaining cost was $788 per ounce.
Diebold Nixdorf Inc, surged 28.7% or $1.50 to $6.73 after the software services provider said revenues in the fourth-quarter ending in December jumped 3.2% from a year ago to $1.3 billion.
Net loss in the quarter widened to $123.6 million or $1.62 per diluted share from $110.1 million or $1.46 in the same quarter last year.
Diebold lifted savings estimate forecast in the three-years to fiscal 2021 to $400 million from $250 million and estimated to lower net debt ratio to less than three times.
Ellie Mae Inc, slid 0.1 cents to $98.88 after the cloud-based platform provider agreed to be acquired by the private equity investment firm Thoma Bravo, LLC $3.7 billion in cash.
Under the terms, Ellie Mae shareholders will receive $99 in cash per share.
The transaction is expected to close in the second or third-quarter of 2019
FLIR Systems Inc, jumped 2.6% or $1.34 to $52.18 after the sensors and imaging systems developer reported revenues in the fourth-quarter ending in December plunged 9.4% from a year ago to $448.5 million.
Net in the quarter swung to a loss of $98.5 million or 71 cents per diluted share from profit of $50.3 million or 36 cents in the same quarter last year.
FLIR forecasted fiscal 2019 revenue growth between 8% and 10% or in the range of $1.92 billion to $1.95 billion and operating income margins in the range of 22% to 23% and diluted earnings per share in the range of $2.30 to $2.36.
Teva Pharmaceutical Industries Ltd, declined 6.9% or $1.32 to $17.80 after the Israel-focused generic drugs maker reported net revenues in the fourth-quarter ending in December slumped 15.6% from a year ago to $4.6 billion.
Net loss in the quarter narrowed to $2.9 billion or $2.85 per diluted share from $11.6 billion or $11.41 in the same quarter last year.
Teva said as of December 31, 2018, net debt declined to $28.9 billion from $32.5 billion in the same period a year ago.